The ₹46-Crore Inventory Gain That Masked Flat Earnings
Reported profit jumped 301%, but three-quarters of it is from a one-time inventory gain on low-cost opening stock. Normalized earnings are flat year-on-year, and management's refusal to upgrade margin guidance signals low conviction on capex-driven improvement.
₹61.7 Cr
+301% YoY
₹46.2 Cr
75% of profit
~₹15.5 Cr
flat YoY
15.46%
normalizes to 7–10%
Century Enka's Q1 FY-2027 results look like a blowout on the headline—revenue up 38%, profit up 301%—but the earnings story is far less impressive once you adjust for a one-time inventory gain. Of the ₹61.7 crore reported PAT, ₹46.24 crore came from a markup on low-cost opening inventory; exclude that, and normalized profit is approximately ₹15.5 crore, essentially flat year-on-year. The quarter's real story is revenue growth that did happen, margin performance that won't repeat, and management's cautious refusal to upgrade guidance despite capex on renewable power and value-added products.
Where the profit really came from
Reported EBITDA of ₹86 crore (15.46% margin) is a stunning print, but management was explicit: this is unsustainable. The headline profit includes a ₹46.24 crore gain on the consumption of low-cost opening inventory purchased at commodity lows. As higher-cost inventory fills the pipeline, this gain reverses. Management reiterated its normalized EBITDA margin guidance of 7–10%—a range they maintained rather than upgraded despite capex initiatives on renewable power (10.5 MW at Bharuch) and value-added product lines. That choice, more than any number, signals their conviction (or lack thereof) on whether capex-driven initiatives will move the needle.
Claims vs. reality
"Record revenue growth 38% YoY, profitability growth 301% YoY"
Revenue growth real; PAT growth 75% driven by ₹46 Cr inventory gain, normalized PAT flat
"EBITDA margin expanded 1050 bps YoY to 15.46%"
Real but unsustainable; management explicitly expects normalization to 7–10% range
"Higher renewable power helped offset energy costs"
Renewable share 40% of consumption; targeting 50% post-H2 commissioning. Benefit acknowledged but unquantified
"Tyre cord fabric +69% to ₹306 Cr"
Matches result; volume growth 12% YoY supports pricing power claim
"Healthy demand across all segments, GST cuts driving growth"
Demand robust but GST split unquantified; Chinese imports at low prices remain headwind
What changed on this call
Three updates stand out. Renewable power expansion: A 10.5 MW capacity at Bharuch (₹8.5 crore equity investment, 26% stake) is planned for commissioning by H2 FY-2027. This will lift renewable power share from 40% to 50% of total consumption and reduce per-ton energy costs—a concrete step, though rupee value unquantified. PTCF approval status: Polyester Tire Cord Fabric remains in the regulatory approval phase; commercial sales are 'expected' in H2 FY-2027 but no customer names, order book, or volume targets have been disclosed. This is the key growth hook for FY-2027, but timeline risk is material. Margin guidance unchanged: Despite these capex initiatives, management reaffirmed the 7–10% normalized EBITDA margin guidance (upgraded from 6–8% in prior calls) and declined to raise it further. This is the most telling signal: they are not confident that initiatives will drive sustainable margin expansion above 7–10%.
The bull-bear ledger
Revenue growth 38% is real, driven by 12% volume growth in tyre cord fabric and filament yarn
GST tailwind and automotive demand strong across 2-wheeler, 3-wheeler, HCV segments
Capex pipeline clear (renewable power, value-add products, mother yarn +3–4k MT in FY-2028)
Reported profit leans 75% on a non-repeating inventory gain
Normalized profit flat YoY despite 38% revenue growth suggests margin pressure
Q2 expected to show margin compression as higher-cost inventory consumed
Capacity at 85–90% utilization with no significant additions in FY-2027 limits organic growth
PTCF (key growth catalyst) still in approval phase; no revenue yet, H2 timing uncertain
Chinese import pricing pressure on commodity filament yarn remains unmitigated
Management tone cautious; declined to upgrade margin guidance despite capex, signaling low conviction
Risks ranked by holder concern
Inventory gain reversal
High₹46 crore one-time gain won't repeat. As higher-cost inventory is consumed, Q2–Q3 will show visible margin compression. Normalized PAT run-rate is ~₹15–20 Cr/Qtr, not ₹61.7 Cr. Investors must reset expectations now or face disappointment.
Raw material volatility
MediumCaprolactam and naphtha prices tied to crude and geopolitical tensions (Iran war). Management flagged ongoing volatility and 'can't guarantee' no re-spike. Without hedging, timing mismatches between input costs and selling prices can crimp margins.
Capacity constraints
MediumCurrently at 85–90% utilization with no major capacity additions in FY-2027. PTCF is the only growth avenue but is unproven. Mother yarn capacity (+3–4k MT) doesn't come online until FY-2028. Growth is structurally capped without PTCF success.
PTCF execution delay
MediumProject flagged as key to FY-2027 upside but remains in regulatory approval phase. Commercial sales 'expected' H2 but no customer names, order book, or volume guidance provided. Delay or worse-than-expected ramp could leave capacity underutilized.
Demand cyclicality
MediumGST cuts (Sept 2025) drove the 38% revenue spike. That tailwind is now ~9 months old and may be saturating. Analysts flagged 'demand air-pocketing' risk when the GST boost effect fades. Management acknowledged cyclicality but can't quantify timing.
Import competition
MediumChinese commodity filament yarn imports at very low prices. Anti-dumping duty not notified despite DGTR approval. Management's mitigation—shift to value-add products—is still in progress and unquantified. Commodity volume/margin risk unresolved.
How the street is positioned
Post-result price action: The stock popped +1.84% on day 1, fading to +1.22% by day 3. This is a tepid reception for a quarter with reported 301% profit growth—the market sniffed out the inventory gain and marked down the quality of the print. For comparison, a cleanly-earned 301% jump would typically draw a sharper rally.
Valuation and momentum: At ₹607.5, the stock trades above its SMA20 (₹554.38), SMA50 (₹528.24), and SMA200 (₹461.13). It sits 9.46% below its all-time high of ₹671 and 63.64% above its 52-week low of ₹371.25. RSI at 79.7 signals overbought conditions—typically a warning flag for near-term pullback risk. The trend is bullish, but technicals are stretched.
Institutional flows: FII ownership has declined from 2.12% (Q3 FY-2026) to 2.06% (Q4 FY-2026), a modest but consistent trim. DII ownership holds steady at 11.04%. Promoter ownership is locked at 24.86%. No rush of institutional buying post-results; if anything, the flat-to-light nibbling suggests cautious positioning.
Insider/block activity: Recent bulk trades (late July) by QE Securities and Microcurves were balanced buys and sells in the ₹634–₹648 range—small-size churn, no major promoter accumulation or selling near the highs. No red flag, but no insider enthusiasm either.
What to watch next
1 · Q2 FY-2027 margin print (Jul–Sep 2026)
Does EBITDA margin compress below 12% as higher-cost inventory is consumed? This will be the market's first test of management's margin-normalization narrative. A run-rate closer to 9–10% would validate guidance; a dip to 8% or below would signal cost pressures are worse than expected.
2 · PTCF regulatory approval and commercial-sales timeline (H2 FY-2027)
Does approval complete and commercial ramp actually commence in H2, or does it slip? First customer names and order-book size will tell investors whether PTCF is a meaningful growth driver or a perpetual pilot program. This is the only material capacity lever in FY-2027.
3 · Renewable power Bharuch commissioning impact (H2 FY-2027)
Once the 10.5 MW capacity is online, does per-ton energy cost actually drop and margin floor strengthen? Quantified benefit in FY-2028 early guidance will tell whether ₹8.5 crore capex is accretive. If benefit is immaterial, it signals high capex intensity for low return.
The verdict
Century Enka delivered solid revenue growth and demonstrated pricing power in its core tyre cord fabric business, but Q1 profit is flattered by a one-time ₹46-crore inventory gain. Strip that, and normalized earnings are flat year-on-year despite 38% revenue growth—a sign that margin pressures (commodity volatility, competition, capacity constraints) are offsetting top-line momentum. Management's refusal to upgrade the 7–10% EBITDA margin guidance, despite capex on renewable power and value-add products, is the most telling signal: they don't believe these initiatives will structurally lift returns in the near term.
The stock is overbought (RSI 79.7), near its all-time high, and institutional buyers are tepid post-results. Capex initiatives are real—Bharuch renewable power, PTCF approval, mother yarn capacity—but they are 2–3 quarters away from material impact and carry execution risk. PTCF is still in regulatory approval with no revenue; renewable power's rupee benefit is unquantified; mother yarn capacity doesn't come online until FY-2028. Near-term, watch for Q2 margin compression as the inventory gain fades and higher-cost goods flow through COGS.
Rating: Hold. The stock is a steady business with real structural tailwinds (GST-driven auto demand, renewable power cost reduction in the pipeline, value-add product mix shift), but this quarter's headline is misleading and the risk/reward is balanced to slightly negative at current valuation. The single number to track from here is normalized EBITDA margin in Q2—if it holds at 8–10%, patience is warranted. If it drops to 6–7%, the guidance is in jeopardy and downside risk rises sharply.
A record revenue quarter masking flat profit. The ₹46-crore inventory gain is a gift that won't repeat. Management knows it; the street is starting to price it in. The real test is whether capex initiatives can lift normalized margins from 7–10% to something sustainably higher—and management isn't betting on it yet.
Century Enka Q1 FY27: consolidated PAT up 4x YoY to ₹61.7 Cr as OPM triples to 15.5%
PAT +301.2% YoY · revenue +38.1% · margins expanding · beat vs street
₹554.29 Cr
+38.1% YoY
₹61.7 Cr
+301.2% YoY
10.96%
+7.3pp YoY
₹28.24
Century Enka's consolidated revenue for the quarter ended 30 June 2026 rose 38.1% YoY to ₹554.29 Cr (₹401.53 Cr in Q1 FY26) and 14.6% QoQ (₹483.53 Cr in Q4 FY26). Consolidated PAT jumped 301% YoY to ₹61.70 Cr (from ₹15.38 Cr) and 56.6% sequentially (from ₹39.40 Cr); EPS was ₹28.24 versus ₹7.04 a year ago. Profit growing far faster than revenue on both a YoY and QoQ basis confirms this is a margin-led beat, not a base-effect or seasonal artifact — there were no exceptional items in either the current quarter or the Q1 FY26 comparison base, so the comparison is clean and organic.
Q1 FY-2027 vs prior quarters
The margin bridge sits mainly on cost structure, not volume: OPM (EBITDA margin) roughly tripled to ~15.5% from 4.95% YoY and improved from 11.83% in Q4 FY26, while NPM rose to 11.13% from 3.70%. Total expenses fell to 87.2% of revenue from 98.7% a year ago — cost of materials as a share of revenue actually rose (66.9% vs 60.8%), but this was more than offset by a large favourable swing in the changes-in-inventories line (-8.3% of revenue vs +0.9% a year ago, i.e. finished-goods stock build reducing the quarter's cost of goods sold), a lower purchases-of-traded-goods ratio (0.2% vs 3.4%), and leaner power & fuel intensity (10.2% vs 11.6% of revenue) — consistent with management's stated cost-reduction and renewable-energy push.
The stock went into the print at ₹633.7, up 24% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
No exceptional items this quarter, unlike Q4 FY26's ₹1.80 Cr Statutory Impact of New Labour Code one-off — a clean, organic comparison
Management guided for improved operating margins in the range of 7% to 10%, driven by cost reduction initiatives, renewable energy adoption, and a focus on value-added products. While specific revenue growth targets are not provided, the company expects to leverage its capacity utilization and new product developments,
— This quarter: beat
Management's own Q4 FY26 guidance called for operating margins of 7-10% via cost reduction, renewable adoption and a value-added product mix; the actual ~15.5% OPM clears that band comfortably, a clear guidance beat. No formal sell-side consensus could be found for this print — the only available external estimate (an automated Univest/Uniresearch trailing-growth model) had projected a YoY decline to ₹9 Cr PAT on ₹306 Cr revenue, and actual results came in far above that, though it is a mechanical projection rather than genuine analyst coverage. Standalone and consolidated results are near-identical this quarter (the associate, ABReL Century Energy, added only ₹0.39 Cr to consolidated PBT), so there is no material divergence between the two bases. The filing carries no separate management press release or commentary beyond the board-outcome letter and financial statements. Corporate-calendar items this quarter — the reappointment of Suresh Sodani as MD & CEO for two more years (21 July) and a further 37-lakh-share acquisition in ABReL Century Energy (23 July) — are continuity signals rather than result-linked drivers.
W1
Whether ~15.5% OPM — well above the guided 7-10% band — sustains into Q2 FY27 as raw-material/power costs normalize
W2
Commercial ramp-up of Polyester Tyre Cord Fabric (PTCF), which management flagged for FY27 but which shows no separate disclosure yet
W3
Progress on the ~₹100 Cr FY27 capex plan for value-added products and capacity expansion, expected to be discussed on the 29 July earnings call
Record quarter masked by ₹46 Cr inventory gain; normalized earnings far softer
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Company met and beat margin guidance (15.5% vs 7-10%) but attributed it explicitly to unsustainable one-off gains; reaffirmed base case 7-10% guidance—no upgrade despite investments.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 headline numbers are strong (38% revenue, 301% PAT) but 75% of profit is from one-time ₹46 Cr inventory gain on low-cost opening stock. Normalized PAT is flat YoY at ~₹15.5 Cr. Management expects margins to normalize to 7-10% (not upgrading despite capex on renewable power and value-add products). Near-term risk: Q2 margin compression as higher-cost inventory is consumed.
₹554.3 Cr
Revenue · +38% YoY₹61.7 Cr
Reported PAT · +301.2% YoYExpanding
Margins · vs guidance: OverstatedDid the claims hold up?
Record revenue growth 38% YoY, profitability growth 301% YoY
OVERSTATEDRevenue growth real; PAT growth 75% driven by ₹46.24 Cr one-time inventory gain, normalized PAT ~₹15.5 Cr
EBITDA margin expanded 1050 bps YoY to 15.46%
MISS15.46% is genuine but unsustainable; management explicitly expects normalization to 7-10% range
Higher renewable power helped offset energy costs
METRenewable share 40% of consumption; targeting 50% post H2 commissioning. Value unquantified but acknowledged positive
Tyre cord fabric +69% to ₹306 Cr
METMatches delivered result; volume growth 12% YoY to 19,199 MT also aligns
Healthy demand across all segments, GST cuts driving growth
METDemand is robust but management can't quantify GST split; commodity imports from China at low prices remain pressure
Earnings quality
What changed since the last call
Inventory gain impact on quarterly results
NewQ1 FY27 benefited from ₹46.24 Cr one-time inventory gain on low-cost opening stock. Management expects this to reverse in coming quarters as higher-cost inventory is consumed; margin normalization explicitly flagged.
Renewable power expansion at Bharuch
Upgrade10.5 MW additional capacity planned (26% equity investment, ₹8.5 Cr capex). When commissioned in H2, renewable share to move 40% → 50%, targeting cost reduction per ton. No prior guidance had this quantum of capex.
Margin guidance reaffirmed, not upgraded
NeutralPrior guidance (FY26 calls) was 7-10% EBITDA margins. Upgraded from 6-8% before that. This call: reaffirmed 7-10%, explicitly stated as 'normalized' and not to be breached. No upside surprise despite capex initiatives.
Value-add product mix shift ongoing
NewInvestment in mother yarn (new WAP), customer-specific filament products to counter commodity imports. Year-over-year increasing but management won't disclose %. All projects have hurdle rate >12-15%, accretive to bottom line.
PTCF approval status progressing, no revenue yet
NeutralApproval process 'moving in desired direction'; commercial sales 'expected' in H2 FY27. No customer names, no order book, no volume guidance. Still pilot phase.
The Q&A
Analysts pushed hard on inventory gain quantification, whether margins would move above 7-10%, GST split of 38% growth. Management disclosed ₹46.24 Cr but was defensive on attribution to EBITDA level. Repeatedly said 'can't give forward-looking statements' and reiterated 7-10% normalized range without enthusiasm. Tone was cautious, not confident.
Inventory gain quantification — Vipul Kumar, Sumangal Investments
Answered₹46.24 Cr disclosed in quarterly filings; reported per stock exchange norms, no further breakdown given
Renewable power contribution — Vipul Kumar, Sumangal Investments
Partial40% currently, targeting 50% after H2 commissioning; won't quantify rupee value but expect bottom-line improvement
GST-driven vs organic growth — Rohan Shah, Eternal Capital
DodgedCan't quantify; GST cut happened Sept 2025, ongoing since then; auto demand across all segments up quarter-on-quarter; geopolitical/crude volatility remain demand risks
Gross margin drivers — Madhur Rathi, CounterCyclical Investments
AnsweredVolume growth from GST boost is the offsetting factor; sharp cost moves drive inventory impact; gradual volatility doesn't move gross margin much
Forward margin trajectory — Madhur Rathi, CounterCyclical Investments
PartialWe upgraded from 6-8% already; will upgrade further once confident initiatives are working and won't breach lower bound; too early to guide higher
Capex and investment payback — Amruta Sane, individual investor
Answered>₹100 Cr FY27; mother yarn capacity FY28 (+3-4k MT); value-add products; renewable power 10.5 MW (₹8.5 Cr equity); all projects targeted for 12-15% minimum IRR
Raw material inventory and sourcing — Amit Kumar, Determined Investment
AnsweredImported materials 25-30 days (incl. transit); domestic 10-15 days; sourcing from China, other countries, domestic suppliers; no availability risk foreseen
Sustainable margin uplift potential — Amit Kumar, Determined Investment
PartialThese drivers are positive but we won't guide higher until proven; will revise once confident we won't breach guidance on lower side; too many variables
Volume outlook and realization stability — Diya Jain, Sapphire Capital
AnsweredQ1 FY27 volume 19,199 MT (vs 17,072 Q1 FY26, 20,711 Q4 FY26); can't guide forward realizations due to volatile pricing
Value-add product realization premium — Madhur Rathi, CounterCyclical Investments
DodgedWon't disclose exact numbers; all investments have hurdle rates >12-15%; accretive to bottom line; purpose is margin + volume protection vs China imports
Guidance
No explicit revenue CAGR given; focused on volume + mix improvement
LowManagement refused forward-looking revenue statements, citing pricing volatility and geopolitical risks. Emphasized demand remains 'encouraging' but no targets provided.
EBITDA margin 7-10% normalized basis (reaffirmed from prior 6-8% upgrade)
MediumMaintained (not upgraded) despite capex on value-add and renewable power. Implies current quarter's 15.46% is outlier. Management will revise 'once confident' initiatives deliver sustainable uplift, avoiding lower-side breach.
FY27: >₹100 Cr (renewable power, value-add products, mother yarn WAP, safety improvements)
HighSpecific allocation: 10.5 MW renewable at Bharuch (₹8.5 Cr equity), mother yarn capacity (FY28: +3-4k MT), value-add product lines. Post-Bharuch Feb 2025 incident, enhanced safety capex.
Risks the call surfaced
One-time gains reversal
High₹46.24 Cr inventory gain (75% of reported PAT) won't repeat. Q2 expected to show margin compression as higher-cost inventory consumed. Normalized PAT run-rate ~₹15-20 Cr/Qtr vs reported ₹61.7 Cr.
Raw material cost volatility
MediumCaprolactam and chip prices volatile due to crude and geopolitical tensions (Iran war). While management has passed through increases, sharp moves can create timing mismatches. Chinese imports at low prices limit pricing power on commodity grades.
Capacity constraints
MediumAt 85-90% capacity utilization with no major capacity additions in FY27. PTCF project (approval phase) is only growth avenue. No new NTCF/filament capacity planned until FY28 mother yarn project (+3-4k MT). Demand outpacing supply could leave growth capped.
PTCF execution delay
MediumPolyester Tire Cord Fabric project key to FY27 growth narrative. Approval process 'moving in desired direction' but no revenue yet. Commercial sales 'expected' in H2 but no firm timeline, customer names, or order book disclosed. Delay risk material.
Demand cyclicality (automotive)
MediumGST cuts (Sept 2025) drove strong auto demand across 2W/3W/HCV. But cuts are now ~9 months old; demand boost may be saturating. Analysts flagged risk of 'demand air pocketing' in Q2-Q3 when GST tailwind fades. Financing availability and economic growth are longer-term drivers.
Import competition (filament yarn)
MediumCommodity filament yarn imported from China at very low prices. Finance Ministry did not notify anti-dumping duty despite DGTR approval. Pressure on commodity volumes and pricing. Management's mitigation: shift to value-add products, but this is still in progress and unquantified.
Management
Score 6/10. Clear on headline results and operational detail (volumes, capex, capacity), but evasive on quality metrics (won't quantify inventory impact at EBITDA level, refuses value-add margin premiums, avoids GST growth split). Repeatedly said 'can't give forward-looking statements' even when analysts asked non-guidance questions. Met prior 7-10% margin guidance (but via one-off gains, not underlying ops). PTCF is behind schedule (approval-stage, no revenue). Value-add capex ongoing but unproven. Renewable power expansion on track (Bharuch 10.5 MW by H2). Track record: cautious, under-promising.
1 · Q2 FY27 (Jul-Sep 2026)
EBITDA margin normalization; higher-cost inventory consumed; visibility to Q2 run-rate
2 · H2 FY27 (Oct 2026–Mar 2027)
PTCF commercial sales commence; renewable power capacity at Bharuch (10.5 MW) commissioned; power cost impact materializes
3 · FY28 (Apr 2027+)
Mother yarn capacity +3-4k MT comes online; value-add product capex matures into margin expansion
Near-term risk: Q2 margin compression as higher-cost inventory is consumed.